All India Institute of Medical Sciences   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: New Delhi India (1956)

Organization Overview

First Clinical Trial
1998
NCT00272116
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Additional Porfessor, Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, New Delhi 110029, India | Additional Professor | Additional Professor, Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, New delhi 110029, India | AIIMS Bhubaneswar | AIIMS, Bhubaneswar | AIIMS BHUBANESWAR | AIIMS, BHUBANESWAR | AIIMS Delhi | AIIMS, Delhi | AIIMS, Delhi, India | AIIMS, New Delhi | AIIMS NEW DELHI | All India Institue of Medical Sciences | All India Institute of Medical Science, Ansari Nagar, New Delhi- 110029, India | All India Institute of Medical Science, New Delhi | All India Institute of Medical Sciences, Bhubaneswar | All India Institute of Medical Sciences Delhi | All India Institute of Medical Sciences, Delhi | All India Institute of Medical Sciences, Guwahati | All India Institute of Medical Sciences, New Delhi | All India Institute of Medical Sciences New Delhi, 110029, India | All India Institute of Medical Sciences, New Delhi, India | ALL INDIA INSTITUTE OF MEDICAL SCIENCES, NEW DELHI, INDIA | All India Institute of Medical Sciences Patna | All India Institute of Medical Sciences, Patna | All India institute of medical sciences, Raipur | All India Institute of Medical Sciences, Rishikesh | All India Institute of Medical Scienes,Patna | Assistant Professor, Deprtament of Microbiology, All India Institute of Medical Sciences, new delhi 110029 | Associate Professor, Department of Endcorinology and Metabolism, All India Institute of Medical Sciences, New Delhi 110029, India | Associate Professor, Department of Endocrinology and Metabolism, All India Institute of MEdical scieneces, New Delhi 110029 | Associate Professor, Department of Neurology, All India Institute of Medical Sciences, New Delhi 110029, India | Associate professor, Department of Transplant immunology and immunogenetics, All India Institute of Medicasl Sciences, New delhi 110029, India | Associate Professor, Depratment of Endocrinology and Metabolism, All India Institute of Medical Sciences, New delhi 110029 | Cambridge Health Alliance Center for Mindfulness and Compassion | Department of Cardiology, All India Institute of Medical Sciences | Department of General Surgery, All India Institute of Medical Sciences, Bhubaneswar, Odisha, INDIA | Department of Neurology, All India Institute of Medical Science (AIIMS), New Delhi, India | Department of Pediatrics, All India Institute of Medical Sciences, New Delhi | dept. of Gastroenterology, A.I.I.M.S. , New Delhi | Dept. of Gastroenterology, All India Institute of Medical Sciences, New Delhi | Dr Atul Sharma | Dr BRA Institute Rotary Cancer Hospital ,All India Institute of Medical Sciences,New Delhi ,India. | Dr. BRA IRCH, AIIMS, New Delhi (India) | Dr RPC, AIIMS | Head, Depratment of Medicine, All India Institute of Medical Sciences, New Delhi 110029 | Head Dept of Medical Oncology, Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India | Institute of Medical Sciences and SUM Hospital Odisha | Institute Rotary Cancer Hospital, AIIMS, New delhi, India | Institute Rotary Cancer Hospital, All India Institute of Medical Sciences | Principal, College of Nursing, All India Institute of Medical Sciences, New Delhi 110029, India | Prof and HOD, Dr RPC, AIIMS | Professor and Head,Department of Medicine, AIIMS, New Delhi-110029 | Professor and Head, Department of Medicine, All India Institute of Medical Sciences, New Delhi, India | Professor and Head, Department of Physcical Medicine and Rehablitation, All India Institute of Medical Sciences, New Delhi 110029, India | PROFESSOR AND HOD, ANAESTHESIOLOGY,AIIMS RISHIKESH | Professor, Department of Pediatrics, All India Institute of Medical Sciences | Ramesh K Agarwal

Active Ingredients

Drugs in Phase 4 Trials (41)

adapalene (differin) (1 trial)

albuterol (proventil) (1 trial)

alpha-lipoic acid (2 trials)

amantadine (symmetrel) (1 trial)

amisulpride (1 trial)

atorvastatin (lipitor) (1 trial)

bosentan (tracleer) (1 trial)

carbamazepine (tegretol) (1 trial)

clindamycin (cleocin) (1 trial)

clozapine (clozaril) (1 trial)

coconut oil (1 trial)

dosulepin (1 trial)

fluoxetine (prozac) (1 trial)

formoterol (foradil) (1 trial)

haloperidol (haldol) (1 trial)

human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant (Gardasil) (1 trial)

inactivated influenza vaccine (1 trial)

insulin glargine (toujeo) (1 trial)

isoniazid (nydrazid) (2 trials)

levothyroxine (Synthroid) (1 trial)

lithium (lithonate) (1 trial)

lurasidone (latuda) (1 trial)

melatonin (1 trial)

metformin (glucophage) (1 trial)

olanzapine (zyprexa) (3 trials)

oxcarbazepine (trileptal) (2 trials)

poliovirus vaccine inactivated (2 trials)

pramipexole (mirapex) (1 trial)

pregabalin (lyrica) (1 trial)

pyrazinamide (Aldinamide) (2 trials)

quetiapine (seroquel) (1 trial)

ramelteon (rozerem) (1 trial)

rifampin (2 trials)

risperidone (risperdal) (1 trial)

sarcosine (1 trial)

sibelium (1 trial)

sildenafil (viagra) (1 trial)

sodium chloride (3 trials)

tapentadol (nucynta) (2 trials)

tazarotene (tazorac) (1 trial)

topiramate (topamax) (1 trial)

Drugs in Phase 3 Trials (73)

albendazole (Albenza) (1 trial)

amphotericin b (fungizone) (1 trial)

aprepitant (Emend) (3 trials)

bacille calmette-guerin (1 trial)

beractant (survanta) (1 trial)

bifidobacterium breve (2 trials)

bifidobacterium infantis (2 trials)

bifidobacterium longum (2 trials)

boric acid (1 trial)

cadisurf (1 trial)

calcium carbonate (1 trial)

capecitabine (xeloda) (2 trials)

ceftriaxone (rocephin) (1 trial)

celecoxib (celebrex) (1 trial)

chlorhexidine (hibitane) (3 trials)

cisplatin (platinol) (3 trials)

Covaxin (2 trials)

cyanocobalamin (berocca) (2 trials)

cyclophosphamide (cytoxan) (2 trials)

cytarabine (cytosar-u) (2 trials)

dexamethasone (1 trial)

doxorubicin (Doxil) (1 trial)

efavirenz (sustiva) (1 trial)

ethambutol (myambutol) (1 trial)

etoposide (vepesid) (2 trials)

fluconazole (diflucan) (1 trial)

folic acid (4 trials)

ginger (1 trial)

hydroxychloroquine (plaquenil) (1 trial)

imidazoquinoline (1 trial)

imiglucerase (cerezyme) (1 trial)

Lactobacillus acidophilus (4 trials)

lactobacillus casei (2 trials)

lactobacillus delbrueckii (2 trials)

lactobacillus plantarum (3 trials)

lactose (3 trials)

lactulose (cephulac) (2 trials)

levocarnitine (carnitor) (1 trial)

lorazepam (ativan) (1 trial)

meropenem (merrem) (1 trial)

methylprednisolone (medrol) (1 trial)

metoclopramide (reglan) (1 trial)

montelukast (singulair) (1 trial)

mycobacterium w vaccine (2 trials)

naltrexone (revia) (1 trial)

nevirapine (viramune) (1 trial)

nicotine (nicorette) (1 trial)

nitroglycerin (transderm-nitro) (1 trial)

norfloxacin (noroxin) (1 trial)

onabotulinumtoxinA (Botox) (1 trial)

ondansetron (zofran) (2 trials)

polyethylene glycol (1 trial)

prednisone (meticorten) (2 trials)

psyllium (1 trial)

safinamide (xadago) (2 trials)

simvastatin (zocor) (1 trial)

sitagliptin (januvia) (4 trials)

streptococcus salivarius (2 trials)

streptokinase (streptase) (2 trials)

sufonylurea (2 trials)

sulbactam (unasyn) (1 trial)

sulfasalazine (azulfidine) (1 trial)

thalidomide (Thalomid) (3 trials)

trc150094 (1 trial)

urea (1 trial)

valdecoxib (bextra) (1 trial)

valproic acid (depakene) (2 trials)

vitamin d3 (4 trials)

voriconazole (vfend) (2 trials)

vsl #3 (2 trials)

water (1 trial)

zinc dichloride (5 trials)

zn2+ (4 trials)

Drugs in Phase 2 Trials (15)

aip-303 (1 trial)

allogeneic adipose derived mesenchymal stem cell (2 trials)

arhalofenate (1 trial)

carboplatin (paraplatin) (2 trials)

chtnt-1 (1 trial)

daunorubicin (cerubidine) (1 trial)

iron (2 trials)

ocimum sanctum (1 trial)

ornithine aspartate (1 trial)

paclitaxel (taxol) (1 trial)

pioglitazone (actos) (1 trial)

ribavirin (virazole) (1 trial)

riviciclib (1 trial)

ruti (1 trial)

varenicline (chantix) (1 trial)

Drugs in Phase 1 Trials (3)

human rotavirus, live attenuated (Rotarix) (1 trial)

l-glutamine (1 trial)

whey protein (1 trial)

Drugs in Other Trials (18)

albumin (Human) (Plasbumin) (1 trial)

azathioprine (imuran) (1 trial)

cyclosporine (sandimmune) (1 trial)

cyproviron (1 trial)

etanercept (enbrel) (1 trial)

ethinyl estradiol (Estinyl) (1 trial)

fenugreek seed extract (1 trial)

ferrous sulfate (1 trial)

honey (1 trial)

infliximab (remicade) (1 trial)

lidocaine (xylocaine) (4 trials)

propofol (diprivan) (1 trial)

sevoflurane (ultane) (1 trial)

tofacitinib (xeljanz) (1 trial)

transcricoid (2 trials)

vitamin a (1 trial)

wheat flour (1 trial)

xylometazoline (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 4)

Acquired Immunodeficiency Syndrome (Phase 3)

Acute Disease (Phase 3)

Arachnoiditis (Phase 3)

Arthritis (Phase 3)

Arthritis, Rheumatoid (Phase 3)

Asthma (Phase 4)

Atrophy (Phase 3)

Bacterial Infections (Phase 3)

Bipolar Disorder (Phase 4)

Brain Diseases (Phase 3)

Breast Neoplasms (Phase 2)

Candidiasis (Phase 3)

Candidiasis, Vulvovaginal (Phase 3)

Carcinoma (Phase 3)

Carcinoma, Hepatocellular (Phase 3)

Carcinoma, Squamous Cell (Phase 2)

Celiac Disease (Phase 3)

Coinfection (Phase 3)

Communicable Diseases (Phase 3)

Coronavirus Infections (Phase 3)

Crohn Disease (Phase 1)

Cysticercosis (Phase 3)

Deglutition Disorders (Phase 3)

Dehydration (Phase 3)

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 2 (Phase 3)

Diabetic Foot (Phase 4)

Diarrhea (Phase 3)

Disease (Phase 4)

Dyslipidemias (Phase 4)

Dystonia (Phase 3)

Fatty Liver (Phase 4)

Fibrosis (Phase 3)

Foot Ulcer (Phase 4)

Gaucher Disease (Phase 3)

Gingival Overgrowth (Phase 3)

Glioblastoma (Phase 2)

Hepatic Encephalopathy (Phase 3)

Hepatic Insufficiency (Phase 2)

Hepatitis (Phase 2)

Hepatitis A (Phase 2)

Hepatitis E (Phase 2)

HIV Infections (Phase 3)

Hyperbilirubinemia (Phase 2)

Hypertension (Phase 4)

Hypertension, Pulmonary (Phase 4)

Hypoxia (Phase 4)

Immunologic Deficiency Syndromes (Phase 3)

Infections (Phase 3)

Influenza, Human (Phase 4)

Ischemia (Phase 2)

Jaundice (Phase 2)

Jaundice, Neonatal (Phase 2)

Leukemia (Phase 3)

Leukemia, Myeloid (Phase 3)

Leukemia, Myeloid, Acute (Phase 3)

Liver Cirrhosis (Phase 3)

Liver Diseases (Phase 4)

Liver Failure (Phase 2)

Liver Failure, Acute (Phase 2)

Lung Diseases (Phase 4)

Lymphoma (Phase 2)

Lymphoma, Mantle-Cell (Phase 2)

Meningitis (Phase 3)

Migraine Disorders (Phase 4)

Mood Disorders (Phase 4)

Mucositis (Phase 3)

Muscular Atrophy (Phase 3)

Muscular Atrophy, Spinal (Phase 3)

Nausea (Phase 3)

Neonatal Sepsis (Phase 3)

Neoplasm Metastasis (Phase 4)

Neoplasms (Phase 3)

Nephrosis (Phase 3)

Nephrotic Syndrome (Phase 3)

Neurocysticercosis (Phase 3)

Non-alcoholic Fatty Liver Disease (Phase 4)

Osteoarthritis (Phase 4)

Osteoarthritis, Knee (Phase 4)

Overweight (Phase 2)

Pain, Postoperative (Phase 4)

Pancreatitis (Phase 3)

Pancreatitis, Chronic (Phase 3)

Parkinson Disease (Phase 3)

Peritonitis (Phase 3)

Pneumonia (Phase 3)

Pneumonia, Ventilator-Associated (Phase 3)

Pyelonephritis (Phase 3)

Recurrence (Phase 2)

Respiratory Distress Syndrome (Phase 3)

Respiratory Distress Syndrome, Newborn (Phase 3)

Rotavirus Infections (Phase 1)

Schizophrenia (Phase 4)

Seizures (Phase 4)

Sepsis (Phase 3)

Severe Acute Respiratory Syndrome (Phase 3)

Squamous Cell Carcinoma of Head and Neck (Phase 2)

Status Epilepticus (Phase 3)

Stomatitis (Phase 3)

Stroke (Phase 2)

Syndrome (Phase 3)

Taeniasis (Phase 3)

Thromboangiitis Obliterans (Phase 2)

Thrombosis (Phase 3)

Tobacco Use Disorder (Phase 2)

Tuberculosis (Phase 4)

Tuberculosis, Meningeal (Phase 3)

Tuberculosis, Pulmonary (Phase 3)

Ulcer (Phase 4)

Urinary Tract Infections (Phase 3)

Uterine Cervical Neoplasms (Phase 4)

Vitamin D Deficiency (Phase 3)

Vomiting (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 126
  • # of Trial APIs: 150